Regulatory and submission strategy
Submission pathways evaluation (eg. priority review, provisional application)
Joint submission evaluation (eg. project ORBIS, ACSS, Asean Joint Assessment)
Dossier review, gap analysis, editing and publishing
Designation preparation (eg. orphan drug)
Labelling review against regulatory standards
Submission modules preparation and review
Dossier submission and follow-up
Receive and review agency questions
Develop effective and concise responses
Evaluation reports review
Finalise artwork and labelling
Review proposed manufacturing changes
Assess regulatory impact and manage submission
Review new safety information
Labelling updates
PSURs submissions
Product licence and GMP renewals
IND (CTN/CTA) review, preparation and submission
HREC and local IRB submission
Study start-up activities for early phase studies (through a partner)
GMP review and applications
CPP and GMP certificate applications
Attending meetings with health agencies (eg. pre-submission, key negotiation)
Regulatory staff training and coaching
Authorised representative for overseas pharma companies
Review of draft regulatory guidance
Regulatory project management
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.